Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy

被引:153
|
作者
Adkins, Irena [1 ,2 ,3 ]
Fucikova, Jitka [1 ,2 ,3 ]
Garg, Abhishek D. [4 ]
Agostinis, Patrizia [4 ]
Spisek, Radek [1 ,2 ,3 ]
机构
[1] Sotio, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic
[3] Charles Univ Prague, Univ Hosp Motol, Prague, Czech Republic
[4] Univ Leuven KU Leuven, Dept Mol & Cell Biol, Cell Death Res & Therapy CDRT Unit, Leuven, Belgium
来源
ONCOIMMUNOLOGY | 2014年 / 3卷 / 12期
关键词
cancer immunotherapy; high hydrostatic pressure; hyperthermia; immunogenic cell death; ionizing irradiation; photodynamic therapy with hypericin; HIGH HYDROSTATIC-PRESSURE; DISTANT UNTREATED TUMORS; REGULATORY T-CELLS; PHOTODYNAMIC-THERAPY; DENDRITIC CELLS; CALRETICULIN EXPOSURE; ANTITUMOR IMMUNITY; ER STRESS; INTRACELLULAR HYPERTHERMIA; IONIZING IRRADIATION;
D O I
10.4161/21624011.2014.968434
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The concept of immunogenic cancer cell death (ICD), as originally observed during the treatment with several chemotherapeutics or ionizing irradiation, has revolutionized the view on the development of new anticancer therapies. ICD is defined by endoplasmic reticulum (ER) stress response, reactive oxygen species (ROS) generation, emission of danger-associated molecular patterns and induction of antitumor immunity. Here we describe known and emerging cancer cell death-inducing physical modalities, such as ionizing irradiation, ultraviolet C light, Photodynamic Therapy (PDT) with Hypericin, high hydrostatic pressure (HHP) and hyperthermia (HT), which have been shown to elicit effective antitumor immunity. We discuss the evidence of ICD induced by these modalities in cancer patients together with their applicability in immunotherapeutic protocols and anticancer vaccine development.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [41] Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy
    Deng, Hongzhang
    Zhou, Zijian
    Yang, Weijing
    Lin, Li-sen
    Wang, Sheng
    Niu, Gang
    Song, Jibin
    Chen, Xiaoyuan
    NANO LETTERS, 2020, 20 (03) : 1928 - 1933
  • [42] Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
    Li, Zhilin
    Lai, Xiaoqin
    Fu, Shiqin
    Ren, Long
    Cai, Hao
    Zhang, Hu
    Gu, Zhongwei
    Ma, Xuelei
    Luo, Kui
    ADVANCED SCIENCE, 2022, 9 (22)
  • [43] Applying nanotechnology to boost cancer immunotherapy by promoting immunogenic cell death
    Lvqin Fu
    Xianbin Ma
    Yuantong Liu
    Zhigang Xu
    Zhijun Sun
    ChineseChemicalLetters, 2022, 33 (04) : 1718 - 1728
  • [44] KCl Nanoparticles as Potential Inducer of Immunogenic Cell Death for Cancer Immunotherapy
    Huang, Zhengjie
    Zhang, Xiaohong
    Luo, Yang
    Wang, Yi
    Zhou, Shaobing
    ACS APPLIED BIO MATERIALS, 2023, 6 (06) : 2404 - 2414
  • [45] Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
    Guo, Yichen
    Ma, Rong
    Zhang, Mengzhe
    Cao, Yongjian
    Zhang, Zhenzhong
    Yang, Weijing
    VACCINES, 2023, 11 (09)
  • [46] Metal-based immunogenic cell death inducers for cancer immunotherapy
    Zou, Jiao Xia
    Chang, Meng Rui
    Kuznetsov, Nikita A.
    Kee, Jia Xuan
    Babak, Maria V.
    Ang, Wee Han
    CHEMICAL SCIENCE, 2025, 16 (15)
  • [47] Recent Progress in Boosted PDT Induced Immunogenic Cell Death for Tumor Immunotherapy
    Jun Li
    Hanlin Ou
    Dan Ding
    Chemical Research in Chinese Universities, 2021, 37 : 83 - 89
  • [48] Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
    Yajie Sun
    Xiangru Feng
    Chao Wan
    Jonathan F.Lovell
    Honglin Jin
    Jianxun Ding
    Asian Journal of Pharmaceutical Sciences, 2021, 16 (02) : 129 - 132
  • [49] Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy
    Xiong, Xiang
    Zhao, Jingya
    Su, Rui
    Liu, Chunping
    Guo, Xing
    Zhou, Shaobing
    NANO TODAY, 2021, 39
  • [50] Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy
    Li, Wenpan
    Jiang, Yanhao
    Lu, Jianqin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 634